Study of regionally different pathomechanism in TDP-43-positive inclusions of amyotrophic lateral sclerosis
| Project/Area Number |
23791006
|
|---|
| Research Category |
Grant-in-Aid for Young Scientists (B)
|
| Allocation Type | Multi-year Fund |
|---|
| Research Field |
Neurology
|
|---|
| Research Institution | Kansai Medical University |
|---|
Principal Investigator |
|
|---|
| Project Period (FY) |
2011 – 2013
|
| Project Status |
Completed (Fiscal Year 2013)
|
| Budget Amount *help |
¥3,510,000 (Direct Cost: ¥2,700,000、Indirect Cost: ¥810,000)
Fiscal Year 2013: ¥650,000 (Direct Cost: ¥500,000、Indirect Cost: ¥150,000)
Fiscal Year 2012: ¥1,560,000 (Direct Cost: ¥1,200,000、Indirect Cost: ¥360,000)
Fiscal Year 2011: ¥1,300,000 (Direct Cost: ¥1,000,000、Indirect Cost: ¥300,000)
|
|---|
| Keywords | ALS / TDP-43 / pSmad2/3 / Smurf2 / TGF-beta / 国際研究者交流 / アメリカ / 培養細胞 / ｐSmad2/3 |
|---|
| Research Abstract |
TDP-43-positive inclusions in lower motor neurones of sporadic Amyotrophic lateral sclerosis (SALS) patients were immunopositive for Smurf2 and pSmad2/3. In contrast, TDP-43-positive inclusions in the extramotor neurones in the brain of SALS patients were noticeably negative for Smurf2 and pSmad2/3. These results demonstrated that the composition of the TDP-43 inclusions is regionally distinct, suggesting different underlying pathogenic processes. We replicated cytoplasmic aggregates of TDP-43 in HEK293T cells by transfecting the cells with a nuclear localization signal deletion mutant of TDP-43 and inhibiting proteasome activity. Overexpression of Smad2 reduced the amount of cytoplasmic aggregates in HEK293T cells, and TGF beta stimulation augmented this reduction effect in a dose-dependent manner. Our results suggest that activation of TGF beta/Smad signaling system may be a potential therapeutic approach to delay the progression of ALS.
|
Report
(4 results)
Research Products
(10 results)
